|
1
|
Wang DZ, Li S, Hockemeyer D, Sutherland L,
Wang Z, Schratt G, Richardson JA, Nordheim A and Olson EN:
Potentiation of serum response factor activity by a family of
myocardin-related transcription factors. Proc Natl Acad Sci USA.
99:14855–14860. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Miralles F, Posern G, Zaromytidou AI and
Treisman R: Actin dynamics control SRF activity by regulation of
its coactivator MAL. Cell. 113:329–342. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pipes GC, Creemers EE and Olson EN: The
myocardin family of transcriptional coactivators: Versatile
regulators of cell growth, migration, and myogenesis. Genes Dev.
20:1545–1556. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li S, Chang S, Qi X, Richardson JA and
Olson EN: Requirement of a myocardin-related transcription factor
for development of mammary myoepithelial cells. Mol Cell Biol.
26:5797–5808. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sun Y, Boyd K, Xu W, Ma J, Jackson CW, Fu
A, Shillingford JM, Robinson GW, Hennighausen L, Hitzler JK, et al:
Acute myeloid leukemia-associated Mkl1 (Mrtf-a) is a key regulator
of mammary gland function. Mol Cell Biol. 26:5809–5826. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Morita T, Mayanagi T and Sobue K: Dual
roles of myocardin-related transcription factors in epithelial
mesenchymal transition via slug induction and actin remodeling. J
Cell Biol. 179:1027–1042. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu WG, Shang YL, Cong XR, Bian X and Yuan
Z: MicroRNA-135b promotes proliferation, invasion and migration of
osteosarcoma cells by degrading myocardin. Int J Oncol.
45:2024–2032. 2014.PubMed/NCBI
|
|
8
|
Medjkane S, Perez-Sanchez C, Gaggioli C,
Sahai E and Treisman R: Myocardin-related transcription factors and
SRF are required for cytoskeletal dynamics and experimental
metastasis. Nat Cell Biol. 11:257–268. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pasquinelli AE, Reinhart BJ, Slack F,
Martindale MQ, Kuroda MI, Maller B, Hayward DC, Ball EE, Degnan B,
Müller P, et al: Conservation of the sequence and temporal
expression of let-7 heterochronic regulatory RNA. Nature.
408:86–89. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Reinhart BJ, Slack FJ, Basson M,
Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR and Ruvkun G:
The 21-nucleotide let-7 RNA regulates developmental timing in
Caenorhabditis elegans. Nature. 403:901–906. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jovanovic M and Hengartner MO: miRNAs and
apoptosis: RNAs to die for. Oncogene. 25:6176–6187. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kondo N, Toyama T, Sugiura H, Fujii Y and
Yamashita H: miR-206 expression is down-regulated in estrogen
receptor alpha-positive human breast cancer. Cancer Res.
68:5004–5008. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou J, Tian Y, Li J, Lu B, Sun M, Zou Y,
Kong R, Luo Y, Shi Y, Wang K, et al: miR-206 is down-regulated in
breast cancer and inhibits cell proliferation through the
up-regulation of cyclin D2. Biochem Biophys Res Commun.
433:207–212. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Taulli R, Bersani F, Foglizzo V, Linari A,
Vigna E, Ladanyi M, Tuschl T and Ponzetto C: The muscle-specific
microRNA miR-206 blocks human rhabdomyosarcoma growth in
xenotransplanted mice by promoting myogenic differentiation. J Clin
Invest. 119:2366–2378. 2009.PubMed/NCBI
|
|
21
|
Zhang T, Liu M, Wang C, Lin C, Sun Y and
Jin D: Down-regulation of MiR-206 promotes proliferation and
invasion of laryngeal cancer by regulating VEGF expression.
Anticancer Res. 31:3859–3863. 2011.PubMed/NCBI
|
|
22
|
Song G, Zhang Y and Wang L: MicroRNA-206
targets notch3, activates apoptosis, and inhibits tumor cell
migration and focus formation. J Biol Chem. 284:31921–31927. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen X, Yan Q, Li S, Zhou L, Yang H, Yang
Y, Liu X and Wan X: Expression of the tumor suppressor miR-206 is
associated with cellular proliferative inhibition and impairs
invasion in ERα-positive endometrioid adenocarcinoma. Cancer Lett.
314:41–53. 2012. View Article : Google Scholar
|
|
24
|
Wang X, Ling C, Bai Y and Zhao J:
MicroRNA-206 is associated with invasion and metastasis of lung
cancer. Anat Rec (Hoboken). 294:88–92. 2011. View Article : Google Scholar
|
|
25
|
Yan D, Dong XE, Chen X, Wang L, Lu C, Wang
J, Qu J and Tu L: MicroRNA-1/206 targets c-Met and inhibits
rhabdomyosarcoma development. J Biol Chem. 284:29596–29604. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Singh A, Happel C, Manna SK,
Acquaah-Mensah G, Carrerero J, Kumar S, Nasipuri P, Krausz KW,
Wakabayashi N, Dewi R, et al: Transcription factor NRF2 regulates
miR-1 and miR-206 to drive tumorigenesis. J Clin Invest.
123:2921–2934. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang L, Liu X, Jin H, Guo X, Xia L, Chen
Z, Bai M, Liu J, Shang X, Wu K, et al: miR-206 inhibits gastric
cancer proliferation in part by repressing cyclin D2. Cancer Lett.
332:94–101. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen CH, Wu ML, Lee YC, Layne MD and Yet
SF: Intronic CArG box regulates cysteine-rich protein 2 expression
in the adult but not in developing vasculature. Arterioscler Thromb
Vasc Biol. 30:835–842. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liao XH, Lu DL, Wang N, Liu LY, Wang Y, Li
YQ, Yan TB, Sun XG, Hu P and Zhang TC: Estrogen receptor α mediates
proliferation of breast cancer MCF-7 cells via a
p21/PCNA/E2F1-dependent pathway. FEBS J. 281:927–942. 2014.
View Article : Google Scholar
|
|
30
|
Kong WQ, Bai R, Liu T, Cai CL, Liu M, Li X
and Tang H: MicroRNA-182 targets cAMP-responsive element-binding
protein 1 and suppresses cell growth in human gastric
adenocarcinoma. FEBS J. 279:1252–1260. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Frankel LB, Christoffersen NR, Jacobsen A,
Lindow M, Krogh A and Lund AH: Programmed cell death 4 (PDCD4) is
an important functional target of the microRNA miR-21 in breast
cancer cells. J Biol Chem. 283:1026–1033. 2008. View Article : Google Scholar
|
|
33
|
Yan LX, Huang XF, Shao Q, Huang MY, Deng
L, Wu QL, Zeng YX and Shao JY: MicroRNA miR-21 overexpression in
human breast cancer is associated with advanced clinical stage,
lymph node metastasis and patient poor prognosis. RNA.
14:2348–2360. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Valastyan S, Reinhardt F, Benaich N,
Calogrias D, Szász AM, Wang ZC, Brock JE, Richardson AL and
Weinberg RA: A pleiotropically acting microRNA, miR-31, inhibits
breast cancer metastasis. Cell. 137:1032–1046. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shimono Y, Zabala M, Cho RW, Lobo N,
Dalerba P, Qian D, Diehn M, Liu H, Panula SP, Chiao E, et al:
Downregulation of miRNA-200c links breast cancer stem cells with
normal stem cells. Cell. 138:592–603. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Miller TE, Ghoshal K, Ramaswamy B, Roy S,
Datta J, Shapiro CL, Jacob S and Majumder S: MicroRNA-221/222
confers tamoxifen resistance in breast cancer by targeting
p27Kip1. J Biol Chem. 283:29897–29903. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yun CH, Choi SC, Park E, Kim SJ, Chung AS,
Lee HK, Lee HJ and Han JK: Negative regulation of Activin/Nodal
signaling by SRF during Xenopus gastrulation. Development.
134:769–777. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Schratt G, Philippar U, Hockemeyer D,
Schwarz H, Alberti S and Nordheim A: SRF regulates Bcl-2 expression
and promotes cell survival during murine embryonic development.
EMBO J. 23:1834–1844. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cao XL, Hu XM, Hu JQ and Zheng WX:
Myocardin-related transcription factor-A promoting neuronal
survival against apoptosis induced by hypoxia/ischemia. Brain Res.
1385:263–274. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ma Z, Morris SW, Valentine V, Li M,
Herbrick JA, Cui X, Bouman D, Li Y, Mehta PK, Nizetic D, et al:
Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13)
of acute mega-karyoblastic leukemia. Nat Genet. 28:220–221. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mercher T, Coniat MB-L, Monni R,
Mauchauffe M, Nguyen Khac F, Gressin L, Mugneret F, Leblanc T,
Dastugue N, Berger R, et al: Involvement of a human gene related to
the Drosophila spen gene in the recurrent t(1;22) translocation of
acute megakaryocytic leukemia. Proc Natl Acad Sci USA.
98:5776–5779. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Descot A, Rex-Haffner M, Courtois G,
Bluteau D, Menssen A, Mercher T, Bernard OA, Treisman R and Posern
G: OTT-MAL is a deregulated activator of serum response
factor-dependent gene expression. Mol Cell Biol. 28:6171–6181.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mercher T, Raffel GD, Moore SA, Cornejo
MG, Baudry-Bluteau D, Cagnard N, Jesneck JL, Pikman Y, Cullen D,
Williams IR, et al: The OTT-MAL fusion oncogene activates
RBPJ-mediated transcription and induces acute megakaryoblastic
leukemia in a knock-in mouse model. J Clin Invest. 119:852–864.
2009.PubMed/NCBI
|
|
44
|
Sasazuki T, Sawada T, Sakon S, Kitamura T,
Kishi T, Okazaki T, Katano M, Tanaka M, Watanabe M, Yagita H, et
al: Identification of a novel transcriptional activator, BSAC, by a
functional cloning to inhibit tumor necrosis factor-induced cell
death. J Biol Chem. 277:28853–28860. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Brandt DT, Baarlink C, Kitzing TM, Kremmer
E, Ivaska J, Nollau P and Grosse R: SCAI acts as a suppressor of
cancer cell invasion through the transcriptional control of
beta1-integrin. Nat Cell Biol. 11:557–568. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Huet G, Mérot Y, Percevault F, Tiffoche C,
Arnal JF, Boujrad N, Pakdel F, Métivier R and Flouriot G:
Repression of the estrogen receptor-alpha transcriptional activity
by the Rho/mega-karyoblastic leukemia 1 signaling pathway. J Biol
Chem. 284:33729–33739. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Evelyn CR, Wade SM, Wang Q, Wu M,
Iñiguez-Lluhí JA, Merajver SD and Neubig RR: CCG-1423: A
small-molecule inhibitor of RhoA transcriptional signaling. Mol
Cancer Ther. 6:2249–2260. 2007. View Article : Google Scholar : PubMed/NCBI
|
